My Hypothesis that Long Hauler's is a Type III Hyper

New Post Public Reply Private Reply Replies (1) Message Board
MGK_2
650
My Hypothesis that Long Hauler's is a Type III Hyper Sensitivity Reaction & a Possible MOA for LL

I've been thinking about this for some time now.

I really believe that Long Hauler Covid is actually a Type 3 Hyper Sensitivity Reaction.

In Type 3, there are Free Antibodies floating in the blood plasma. They are called Serum Immune Complexes. They are antigen-antibody complexes. For long haulers, the antigen-antibody complex would be the more numerous <covid 19 Spike protein mated with the antibody our body made against the spike protein> OR less in number <covid 19 Spike protein mated with the vaccination antibody given to us in vaccine>.

Type 3 is a rather delayed reaction.

Type 1 is fastest, such as after a bee sting, which could be immediate anaphylaxis or an asthma, angioedema, (usually humoral pre-formed antibodies, IgE, eosinophil mediated, mast cell, histamine),

Type 2 is like Type 3 with antigen-antibody complex, but it is not free floating in the blood. Rather, the complex is attached to the cell, so it is cytotoxic. An example of this hypersensitivity reaction is when your body rejects organs in Graft vs. Host Disease, or Myasthenia Gravis / Pemphigus Vulgaris which are more delayed than immediate.

Type 4, is cell to cell mediated hypersensitivity. The T cells do the killing, not the antibody. Here T Cells and Cytokines, CD4 T lymphocytes secrete interferon gamma which stimulate macrophages to make a granuloma. It is the most delayed and the slowest because it takes a long time to make a granuloma which are found in Tuberculosis, histoplasmosis, coccidiomycosis or Sarcoidosis.

Long Covid is right up this time range. It comes on 2-3 weeks after a person had covid and can last for months to years it seems.

Since the antigen-antibody complex is in the blood, it is circulating through out the body. This complex can end up being deposited in the wall of the blood vessels causing Vasculitis, into the joints, causing immune-complex Arthritis which is what happens in Rheumatoid Arthritis & Lupus, they can get stuck in the kidneys, causing immune-complex mediated Nephritis, in the liver causing Hepatitis (children found with hepatitis following vaccination), in the heart, causing myoCarditis (following covid and following vaccine), etc, etc. All of these are common in Long Covid and even following vaccination.

Type 3 could be a generalized reaction all over the body or it could be a localized reaction. When these antigen-antibody complexes are deposited all over the body, into all the tissues and organs, the Complement Cascade system is activated via IgM antibody 1st and IgG 2nd response, (very good at Complement Activation) and subsequently, the patient gets a shit load of C-complements (proteins) into the blood as well. Complements are proteins made by the liver, leading to the complement cascade which results in the MAC which attacks all foreigners. This Complement System acts like a link or a bridge between the Innate and Adaptive Immunity. Complements are made by the liver to help fight the invader, the antigen-antibody complex. The end result of the Complement Cascade results in an entity called the Membrane Attack Complex, MAC which destroys the antigen-antibody complex. But, in a massive overload situation, they may destroy the tissues as well. Why? Because these complexes are deposited in the tissues of the body.

In a massive overload situation as in long covid (long term), or post vaccination syndrome, (short term), this could result in Hypocomplementemia because all the complements are being consumed being used over and over and over again, to destroy the myriad of antigen-antibody complexes imbedded in the tissues. A real life example of hypocomplementemia is lupus, an auto-immune disease where the body creates MAC, but there are no antigen-antibody complexes, so the body is attacking itself, destroying its own tissues. Many Rheumatological disease like RA have increased complement which leads to joint deformity, kidney disease glomerulonephritis, vascular, endocarditis, myocarditis, vasculitis.

Another idea here is that if the liver is weakened by the huge deposition of antibody-antigen complexes and it is spurred into manufacture of all these complements, but it can not do so because it is itself infected with the antibody-antigen complexes and is therefore unable to develop the building blocks of the MACs via the cascade. That would mean that the only way to get rid of these antibody-antigen complexes is either waiting for them to disintegrate in the tissues or by our Natural Killer Cells.

One test to determine if there is a Complement Deficiency in Long Covid would be the CH50 test. It's a screening test of the Markers which indicate the cascade. If it is low, then order the Early Complement Level. We would expect C4 to be low for it to indicate a Classical Pathway, (auto-immune) pointing to Long Covid or post viral.

There is a complement system regulating protein called Decay Accelerating Factor (DAF) which, on the cell's surface, inhibits both complement 3 convertase and complement 5 convertase; another action is to inhibit Natural Killer Cells, both of which may be how the cells are protected from getting destroyed by the complements. DAF interferes with the escalation of the complement cascade whos final result is the Membrane Attack Complex, (MAC); MAC fails to develop.

I'm guessing here, but I'm considering that Leronlimab may have an effect in upregulation of DAF so the tissues can heal while the antigen-antibody complexes get destroyed by Natural Killer Cells which we already know are suppressed by T regulator cells when Leronlimab is given. So Leronlimab may have a double effect on curbing the onslaught on these antigen-antibody complexes, but may prolong the time it takes to get rid of them.

Leronlimab, being a CCR5 blockade, binds to CCR5 with greatest affinity. Therefore, when it is introduced, it displaces any other cytokine attached to CCR5. This gains control of the Natural Killer Cells. It seems to have a regulating effect. A taming effect, reducing the rampant destruction of everything and anything that it doesn't like.

I suspect Leronlimab achieves this Taming Effect on our Immune Response by Activation of the Tregulatory Cells, the T suppressor cells. By activation of these T helper cells, the Immune Cascade is Tamed, it is quieted, it is quelled leading to less inflammation, less swelling, fewer side effects of the war, fewer symptoms. T regs prevent the attack upon our own cells and develop "Tolerance" of what is "Self" vs. "Non-Self or Foreign" thereby preventing Auto-Immune Disease which in effect a form of this Type III Hypersensitivity Reaction. Does Long Covid = Auto-Immune Disease???

AIDS, Acquired ImmunoDeficiency Syndrome is the attack on CD4+ T-Lymphocytes. That is an attack on T helper cells. T regulatory / T suppressor cells. When you kill these T helper lymphocytes, you kill the Adaptive Immune System. No help. B Lymphocytes are left clueless. Natural Killer cells are clueless. Leronlimab shuts down HIV 1 attack, (not HIV 2), and therefore eradicates AIDS when caused by HIV 1.

I think, although we most definitely can say that Leronlimab is a CCR5 blockade, we should probably say the its Mechanism of Action in the majority of its indications will be a T helper cell regulator. T helper cells help other T cells. It also helps Humoral Immunity by helping the B lymphocytes. T helper cells help T cytotoxic cells kill. They help T regulatory cells control/suppress/regulate the cell mediated attack. (T suppressor cells are now called T regulator cells and they help the immune system do its job, but they can suppress it too, so that the immune system does not kill self.) Leronlimab permits the passive response of the immune system, (memory, production of antibodies), while cutting down on the flank attack, (Tcytotoxic cells, Natural Killer Cells), therefore allows the generalized work of getting to the core of the problem without inducing secondary harm in the process. Therefore, the "real" Mechanism of Action that Leronlimab Helps the T helper cell. CCL5 RANTES is main deceiver of the T helper cell, but Leronlimab displaces CCL5 RANTES from its control of this incredibly important component of Cell-mediated Active Immunity and restores appropriate control of this cellular- immunoregulation necessary to promote recognition of self vs. non self.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

DKS Lawsuit Deadline: Investors Must Act by Nov 3, 2026

Updated Category News Views 125

Clock's Ticking for DICK'S Investors If you've got money tied up in DICK'S Sporting Goods—bought between September 8, 2025, and August 24, 2026—listen up. There's a class action lawsuit aiming to recover some of what might've slipped through your fingers. Come November 3, 2026, the door slams shut on your chance to get involved. What's the Beef? Apparently, DICK'S had...

Continue Reading
Context Labs Unveils AI Distillery for Enterprises

Updated Category News Views 271

Rethinking AI with Sovereignty in Mind A bouquet of tech buzzwords lands on every investor's doorstep with the unveiling of Context Labs' latest contraption. We’re talking about the AI Distillery™, which promises enterprises a way to run sovereign AI systems by keeping data in-house. Now, if you’re nodding along to the buzz, let's cut through the clutter....

Continue Reading
UBCF & GGP Join Forces for Nationwide Pink Bag Drive

Updated Category News Views 211

Caring Through Community: Pink Bag Events Unroll What do you get when compassion meets action? That's the story with the United Breast Cancer Foundation (UBCF) and GGP's Pink Bag Event. Here in 2026, these folks are doing something so damn important, you'd wonder why more don’t follow suit. For the fifth straight year, they're rolling out a campaign that bridges the gap...

Continue Reading
SCANOLOGY's AirGO Pad Revolutionizes On-Site Inspections

Updated Category News Views 229

Mobile 3D Scanning — Finally, Some Real Innovation Gone are the days where engineers had to cart around bulky laptops just to finish a simple inspection. SCANOLOGY has thrown a real game-changer into the mix with their new AirGO Pad. It's essentially a slick tablet that keeps your scanning, inspecting, and reporting all in one place, right beside whatever tangled hunk...

Continue Reading
HanAll F&B Pioneers New Path for Domestic Rice Noodles

Updated Category News Views 316

New Spin on an Old Favorite: Rice Noodles Forget about the same old wheat noodles clogging up the pantry. HanAll F&B is revamping the noodle game with a homegrown twist, setting sights on a future where Korean rice isn't just for steaming, soup, or sushi. This outfit from Taebaek, Gangwon, has got its hands deep in the rice flour, finessing a patent that aims to make...

Continue Reading
HK Boosts Oversight of Building Repairs Post-Blaze

Updated Category News Views 222

Big Moves After a Tragic Fire Hong Kong's revamping its approach to building maintenance and oversight, clearly in reaction to the horrific Wang Fuk Court blaze last year. That fire didn't just leave scars; it blew open glaring gaps in the city's oversight of building repairs. The government's now jumping into action by launching a raft of measures aimed at preventing...

Continue Reading
Race for Life Rescue Logs 200 Flights for Shelter Pets

Updated Category News Views 188

Airborne Lifelines for Vulnerable Animals Ever picture an airplane filled with hope? Well, Race for Life Rescue isn't just carting metal through the sky; they're lifting spirits, one furry passenger at a time. Picture this: a nonprofit turning a clunky Beechcraft into a flying ark, whisking away 112 at-risk pets from Louisiana to fresh starts in the Northeast. And guess...

Continue Reading
iTLC Traffic Systems Expand Global Reach at APTA 2026

Updated Category News Views 126

APTA 2026: The Launchpad for Intelligent Traffic Control Forget the days of manual traffic chaos—by the sounds of it, smart intersections are ready to rule the roads. Today's chatter at APTA 2026 in Chicago was a whirlwind of ideas, all centered around how ICP DAS and Towards Buddha Co., Ltd. plan to shake up traffic management globally with their iTLC Intelligent...

Continue Reading
NABEP's Strategic Push: 41 Rigs to Bolster Output

Updated Category News Views 316

On The Ground: NABEP's Expanding Venezuelan Presence Think of oil production as a high-stakes poker game where each drill and rig is a well-placed bet. North American Blue Energy Partners (NABEP) is going all in on Venezuela, boosting their rig fleet and pushing production capacity to new heights. Set your sights on November when NABEP's in-country fleet will hit 41 rigs...

Continue Reading
OlloBot's Emotional AI Robots Connect Beyond Tasks

Updated Category News Views 248

OlloBot Eyes Emotional Bonds, Not Just Robotics Power Is it just me, or is OlloBot onto something deep with their emotional AI companions? They've set a course that might just redefine how we perceive home robotics. At IFA Berlin 2026, they didn't just strut their technical stuff. Nope, they took it beyond gears and gadgets, turning heads with a robot that does more than...

Continue Reading

Top 5 Most Recently Viewed Articles

AVIXA Unveils Exciting New Event: InfoComm EDGE 2026

Updated Category News Views 103

AVIXA Introduces InfoComm EDGE: A Groundbreaking Event AVIXA is thrilled to present InfoComm EDGE, an innovative two-day experiential showcase set to take place at the Festival Arena. This event invites key industry stakeholders to engage with and explore the latest advancements in pro AV technology. Set against the backdrop of a reimagined expo, InfoComm EDGE aims to...

Continue Reading
Discovering Wealth Opportunities with AI and XRP

Updated Category News Views 158

AI-Driven Wealth Opportunities in the Digital Age In a rapidly evolving financial landscape, the convergence of artificial intelligence and blockchain technology is reshaping how we perceive wealth creation. One standout player in this realm is Ripple (XRP), which is gaining momentum alongside established coins like Bitcoin (BTC), Litecoin (LTC), and Ethereum Classic...

Continue Reading
Congress Urged to Act on Substance Use Crisis Now

Updated Category News Views 194

Urgent Action Required to Combat Substance Use Crisis As the United States grapples with a worsening crisis of substance use and substance use disorder (SUD), organizations like Shatterproof are advocating for immediate action from Congress. Over the past four years, overdose deaths have surged to alarming levels, with millions of Americans grappling with addiction. This...

Continue Reading
Understanding Recent Trends in Capri Holdings Options Activity

Updated Category News Views 217

Examining Recent Options Activity for Capri Holdings Today’s financial markets have revealed some fascinating insights, particularly concerning Capri Holdings (CPRI). It appears that influential investors are adopting a bearish outlook, which has drawn the attention of retail investors to the unusual options activity surrounding Capri. Publicly available options data...

Continue Reading
Tritent's Acquisition of FanTribe: A New Chapter in Growth

Updated Category News Views 247

Tritent International Corp. Expands Portfolio with FanTribe Acquisition SUMMARY Tritent International Corp. has made a significant move by acquiring 100% of FanTribe in a tax-free, all-share transaction. This acquisition enhances Tritent's position in the rapidly growing $528 billion creator economy, further cementing its commitment to innovative growth. Enhancing...

Continue Reading